Alessandro Passardi|Mimma Rizzo|Francesca Maines|Carlo Tondini|Alberto Zambelli|Roberto Vespignani|Daniele Andreis|Oriana Nanni|Marco Dianti|Stefano Forti|Enrico Maria Piras|Claudio Eccher
Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility study
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori|Istituti di Ricovero e Cura a Carattere Scientifico|Provincia Autonoma di Trento|Provincia Autonoma di Trento|Ospedale Papa Giovanni XXIII|Ospedale Papa Giovanni XXIII|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori|Istituti di Ricovero e Cura a Carattere Scientifico|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori|Istituti di Ricovero e Cura a Carattere Scientifico|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori|Istituti di Ricovero e Cura a Carattere Scientifico|Fondazione Bruno Kessler|Fondazione Bruno Kessler|Fondazione Bruno Kessler|Fondazione Bruno Kessler
despite growing number oral agents available cancer treatment efficacy may reduced due lack adherence inappropriate adverse event selfmanagement arbitrary dose adjustment management anticancer therapies could exponentially benefit introduction mobile health technologies highly integrated electronic oncology systemwe plan customise finetune existing monitoring trec platform used different chronic diseases oncology setting project follows multistep approach two major purposes 1 participatory design techniques driven health literacy patient reported outcomes principles order adapt system oncology setting involving patients healthcare providers 2 prospective trainingvalidation interventional nonpharmacological multicentre study series consecutive patients cancer 20 60 patients training validation steps respectively order assess system capability usability acceptability novel oncotrec 20 expected contribute improving adherence safety cancer care promoting patient empowerment patientdoctor communicationethical approval obtained independent ethics committees participating institutions ceiiav protocol number 25492015 reference number 1315pu informed consent obtained study participants findings disseminated peerreviewed journals conferences event presentationsclinicaltrialsgov nct02921724 preresults study id number irst10018